CCR5 (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "CCR5" in Italian language version.

refsWebsite

Global rank Italian rank

21doi.org

2^nd place

7^th place

20nih.gov

4^th place

9^th place

10oadoi.org

799^th place

22^nd place

7archive.org

6^th place

8^th place

2web.archive.org

1^st place

1science.org

1,160^th place

2,091^st place

1plos.org

2,112^th place

2,144^th place

1wsj.com

79^th place

214^th place

1clinicaltrials.gov

5,225^th place

5,296^th place

1nytimes.com

7^th place

19^th place

archive.org

Stephens JC, Reich DE, Goldstein DB, Shin HD, Smith MW, Carrington M, Winkler C, Huttley GA, Allikmets R, Schriml L, Gerrard B, Malasky M, Ramos MD, Morlot S, Tzetis M, Oddoux C, di Giovine FS, Nasioulas G, Chandler D, Aseev M, Hanson M, Kalaydjieva L, Glavac D, Gasparini P, Kanavakis E, Claustres M, Kambouris M, Ostrer H, Duff G, Baranov V, Sibul H, Metspalu A, Goldman D, Martin N, Duffy D, Schmidtke J, Estivill X, O'Brien SJ, Dean M, Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes, in Am. J. Hum. Genet., vol. 62, n. 6, giugno 1998, pp. 1507–15, DOI:10.1086/301867, PMC 1377146, PMID 9585595.
Buseyne F, Janvier G, Teglas JP, Ivanoff S, Burgard M, Bui E, Mayaux MJ, Blanche S, Rouzioux C, Rivière Y, Impact of heterozygosity for the chemokine receptor CCR5 32-bp-deleted allele on plasma virus load and CD4 T lymphocytes in perinatally human immunodeficiency virus-infected children at 8 years of age, in J. Infect. Dis., vol. 178, n. 4, ottobre 1998, pp. 1019–23, DOI:10.1086/515660, PMID 9806029.
Freitas T, Brehm A, Fernandes AT, Frequency of the CCR5-delta32 mutation in the Atlantic island populations of Madeira, the Azores, Cabo Verde, and São Tomé e Príncipe, in Hum. Biol., vol. 78, n. 6, dicembre 2006, pp. 697–703, DOI:10.1353/hub.2007.0011, PMID 17564248.
Hedrick PW, Verrelli BC, "Ground truth" for selection on CCR5-Delta32, in Trends Genet., vol. 22, n. 6, giugno 2006, pp. 293–6, DOI:10.1016/j.tig.2006.04.007, PMID 16678299.
Glass WG, McDermott DH, Lim JK, Lekhong S, Yu SF, Frank WA, Pape J, Cheshier RC, Murphy PM, CCR5 deficiency increases risk of symptomatic West Nile virus infection, in J. Exp. Med., vol. 203, n. 1, gennaio 2006, pp. 35–40, DOI:10.1084/jem.20051970, PMC 2118086, PMID 16418398.
Duncan SR, Scott S, Duncan CJ, Reappraisal of the historical selective pressures for the CCR5-Delta32 mutation, in J. Med. Genet., vol. 42, n. 3, marzo 2005, pp. 205–8, DOI:10.1136/jmg.2004.025346, PMC 1736018, PMID 15744032.
Agrawal L, Lu X, Qingwen J, VanHorn-Ali Z, Nicolescu IV, McDermott DH, Murphy PM, Alkhatib G, Role for CCR5Delta32 protein in resistance to R5, R5X4, and X4 human immunodeficiency virus type 1 in primary CD4+ cells, in J. Virol., vol. 78, n. 5, marzo 2004, pp. 2277–87, DOI:10.1128/JVI.78.5.2277-2287.2004, PMC 369216, PMID 14963124.

clinicaltrials.gov

Autologous T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728 for HIV (Zinc-Finger), su clinicaltrials.gov, U.S. National Institutes of Health, 9 dicembre 2009. URL consultato il 30 dicembre 2009.

doi.org

dx.doi.org

Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, Farber CM, Saragosti S, Lapoumeroulie C, Cognaux J, Forceille C, Muyldermans G, Verhofstede C, Burtonboy G, Georges M, Imai T, Rana S, Yi Y, Smyth RJ, Collman RG, Doms RW, Vassart G, Parmentier M, Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene, in Nature, vol. 382, n. 6593, agosto 1996, pp. 722–5, DOI:10.1038/382722a0, PMID 8751444.
Samson M, Labbe O, Mollereau C, Vassart G, Parmentier M, Molecular cloning and functional expression of a new human CC-chemokine receptor gene, in Biochemistry, vol. 35, n. 11, marzo 1996, pp. 3362–7, DOI:10.1021/bi952950g, PMID 8639485.
Slimani H, Charnaux N, Mbemba E, Saffar L, Vassy R, Vita C, Gattegno L, Interaction of RANTES with syndecan-1 and syndecan-4 expressed by human primary macrophages, in Biochim. Biophys. Acta, vol. 1617, 1–2, ottobre 2003, pp. 80–8, DOI:10.1016/j.bbamem.2003.09.006, PMID 14637022.
Struyf S, Menten P, Lenaerts JP, Put W, D'Haese A, De Clercq E, Schols D, Proost P, Van Damme J, <2170::AID-IMMU2170>3.0.CO;2-D Diverging binding capacities of natural LD78beta isoforms of macrophage inflammatory protein-1alpha to the CC chemokine receptors 1, 3 and 5 affect their anti-HIV-1 activity and chemotactic potencies for neutrophils and eosinophils, in Eur. J. Immunol., vol. 31, n. 7, luglio 2001, pp. 2170–8, DOI:10.1002/1521-4141(200107)31:7<2170::AID-IMMU2170>3.0.CO;2-D, PMID 11449371.
Proudfoot AE, Fritchley S, Borlat F, Shaw JP, Vilbois F, Zwahlen C, Trkola A, Marchant D, Clapham PR, Wells TN, The BBXB motif of RANTES is the principal site for heparin binding and controls receptor selectivity, in J. Biol. Chem., vol. 276, n. 14, aprile 2001, pp. 10620–6, DOI:10.1074/jbc.M010867200, PMID 11116158.
Miyakawa T, Obaru K, Maeda K, Harada S, Mitsuya H, Identification of amino acid residues critical for LD78beta, a variant of human macrophage inflammatory protein-1alpha, binding to CCR5 and inhibition of R5 human immunodeficiency virus type 1 replication, in J. Biol. Chem., vol. 277, n. 7, febbraio 2002, pp. 4649–55, DOI:10.1074/jbc.M109198200, PMID 11734558.
(EN) Fiorenza Cocchi, Anthony L. DeVico e Paolo Lusso, Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8 + T Cells, in Science, vol. 270, n. 5243, 15 dicembre 1995, pp. 1811–1815, DOI:10.1126/science.270.5243.1811. URL consultato l'11 dicembre 2024.
Anderson J, Akkina R, Complete Knockdown of CCR5 by lentiviral vector-expressed siRNAs and protection of transgenic macrophages against HIV-1 infection, in Gene Therapy, vol. 14, n. 14, 2007, pp. 1287–1297, DOI:10.1038/sj.gt.3302958, PMID 17597795.
Galvani AP, Slatkin M, Evaluating plague and smallpox as historical selective pressures for the CCR5-Delta 32 HIV-resistance allele, in Proc. Natl. Acad. Sci. U.S.A., vol. 100, n. 25, dicembre 2003, pp. 15276–9, DOI:10.1073/pnas.2435085100, PMC 299980, PMID 14645720.
Stephens JC, Reich DE, Goldstein DB, Shin HD, Smith MW, Carrington M, Winkler C, Huttley GA, Allikmets R, Schriml L, Gerrard B, Malasky M, Ramos MD, Morlot S, Tzetis M, Oddoux C, di Giovine FS, Nasioulas G, Chandler D, Aseev M, Hanson M, Kalaydjieva L, Glavac D, Gasparini P, Kanavakis E, Claustres M, Kambouris M, Ostrer H, Duff G, Baranov V, Sibul H, Metspalu A, Goldman D, Martin N, Duffy D, Schmidtke J, Estivill X, O'Brien SJ, Dean M, Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes, in Am. J. Hum. Genet., vol. 62, n. 6, giugno 1998, pp. 1507–15, DOI:10.1086/301867, PMC 1377146, PMID 9585595.
Buseyne F, Janvier G, Teglas JP, Ivanoff S, Burgard M, Bui E, Mayaux MJ, Blanche S, Rouzioux C, Rivière Y, Impact of heterozygosity for the chemokine receptor CCR5 32-bp-deleted allele on plasma virus load and CD4 T lymphocytes in perinatally human immunodeficiency virus-infected children at 8 years of age, in J. Infect. Dis., vol. 178, n. 4, ottobre 1998, pp. 1019–23, DOI:10.1086/515660, PMID 9806029.
Faure E, Royer-Carenzi M, Is the European spatial distribution of the HIV-1-resistant CCR5-Delta32 allele formed by a breakdown of the pathocenosis due to the historical Roman expansion?, in Infect. Genet. Evol., vol. 8, n. 6, dicembre 2008, pp. 864–74, DOI:10.1016/j.meegid.2008.08.007, PMID 18790087.
Freitas T, Brehm A, Fernandes AT, Frequency of the CCR5-delta32 mutation in the Atlantic island populations of Madeira, the Azores, Cabo Verde, and São Tomé e Príncipe, in Hum. Biol., vol. 78, n. 6, dicembre 2006, pp. 697–703, DOI:10.1353/hub.2007.0011, PMID 17564248.
Hedrick PW, Verrelli BC, "Ground truth" for selection on CCR5-Delta32, in Trends Genet., vol. 22, n. 6, giugno 2006, pp. 293–6, DOI:10.1016/j.tig.2006.04.007, PMID 16678299.
Glass WG, McDermott DH, Lim JK, Lekhong S, Yu SF, Frank WA, Pape J, Cheshier RC, Murphy PM, CCR5 deficiency increases risk of symptomatic West Nile virus infection, in J. Exp. Med., vol. 203, n. 1, gennaio 2006, pp. 35–40, DOI:10.1084/jem.20051970, PMC 2118086, PMID 16418398.
Duncan SR, Scott S, Duncan CJ, Reappraisal of the historical selective pressures for the CCR5-Delta32 mutation, in J. Med. Genet., vol. 42, n. 3, marzo 2005, pp. 205–8, DOI:10.1136/jmg.2004.025346, PMC 1736018, PMID 15744032.
Sabeti PC, Walsh E, Schaffner SF, Varilly P, Fry B, Hutcheson HB, Cullen M, Mikkelsen TS, Roy J, Patterson N, Cooper R, Reich D, Altshuler D, O'Brien S, Lander ES, The case for selection at CCR5-Delta32, in PLoS Biol., vol. 3, n. 11, novembre 2005, pp. e378, DOI:10.1371/journal.pbio.0030378, PMC 1275522, PMID 16248677.
Steinberger P, Andris-Widhopf J, Bühler B, Torbett BE, Barbas CF, Functional deletion of the CCR5 receptor by intracellular immunization produces cells that are refractory to CCR5-dependent HIV-1 infection and cell fusion, in Proc. Natl. Acad. Sci. U.S.A., vol. 97, n. 2, gennaio 2000, pp. 805–10, DOI:10.1073/pnas.97.2.805, PMC 15412, PMID 10639161.
Hütter G, Nowak D, Mossner M, Ganepola S, Müssig A, Allers K, Schneider T, Hofmann J, Kücherer C, Blau O, Blau IW, Hofmann WK, Thiel E, Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation, in N. Engl. J. Med., vol. 360, n. 7, febbraio 2009, pp. 692–8, DOI:10.1056/NEJMoa0802905, PMID 19213682.
Agrawal L, Lu X, Qingwen J, VanHorn-Ali Z, Nicolescu IV, McDermott DH, Murphy PM, Alkhatib G, Role for CCR5Delta32 protein in resistance to R5, R5X4, and X4 human immunodeficiency virus type 1 in primary CD4+ cells, in J. Virol., vol. 78, n. 5, marzo 2004, pp. 2277–87, DOI:10.1128/JVI.78.5.2277-2287.2004, PMC 369216, PMID 14963124.
Allers K, Hütter G, Hofmann J, Loddenkemper C, Rieger K, Thiel E, Schneider T, Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation, in Blood, vol. 117, n. 10, dicembre 2010, pp. 2791–2799, DOI:10.1182/blood-2010-09-309591, PMID 21148083.

nih.gov

ncbi.nlm.nih.gov

Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, Farber CM, Saragosti S, Lapoumeroulie C, Cognaux J, Forceille C, Muyldermans G, Verhofstede C, Burtonboy G, Georges M, Imai T, Rana S, Yi Y, Smyth RJ, Collman RG, Doms RW, Vassart G, Parmentier M, Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene, in Nature, vol. 382, n. 6593, agosto 1996, pp. 722–5, DOI:10.1038/382722a0, PMID 8751444.
Samson M, Labbe O, Mollereau C, Vassart G, Parmentier M, Molecular cloning and functional expression of a new human CC-chemokine receptor gene, in Biochemistry, vol. 35, n. 11, marzo 1996, pp. 3362–7, DOI:10.1021/bi952950g, PMID 8639485.
Slimani H, Charnaux N, Mbemba E, Saffar L, Vassy R, Vita C, Gattegno L, Interaction of RANTES with syndecan-1 and syndecan-4 expressed by human primary macrophages, in Biochim. Biophys. Acta, vol. 1617, 1–2, ottobre 2003, pp. 80–8, DOI:10.1016/j.bbamem.2003.09.006, PMID 14637022.
Struyf S, Menten P, Lenaerts JP, Put W, D'Haese A, De Clercq E, Schols D, Proost P, Van Damme J, <2170::AID-IMMU2170>3.0.CO;2-D Diverging binding capacities of natural LD78beta isoforms of macrophage inflammatory protein-1alpha to the CC chemokine receptors 1, 3 and 5 affect their anti-HIV-1 activity and chemotactic potencies for neutrophils and eosinophils, in Eur. J. Immunol., vol. 31, n. 7, luglio 2001, pp. 2170–8, DOI:10.1002/1521-4141(200107)31:7<2170::AID-IMMU2170>3.0.CO;2-D, PMID 11449371.
Proudfoot AE, Fritchley S, Borlat F, Shaw JP, Vilbois F, Zwahlen C, Trkola A, Marchant D, Clapham PR, Wells TN, The BBXB motif of RANTES is the principal site for heparin binding and controls receptor selectivity, in J. Biol. Chem., vol. 276, n. 14, aprile 2001, pp. 10620–6, DOI:10.1074/jbc.M010867200, PMID 11116158.
Miyakawa T, Obaru K, Maeda K, Harada S, Mitsuya H, Identification of amino acid residues critical for LD78beta, a variant of human macrophage inflammatory protein-1alpha, binding to CCR5 and inhibition of R5 human immunodeficiency virus type 1 replication, in J. Biol. Chem., vol. 277, n. 7, febbraio 2002, pp. 4649–55, DOI:10.1074/jbc.M109198200, PMID 11734558.
Anderson J, Akkina R, Complete Knockdown of CCR5 by lentiviral vector-expressed siRNAs and protection of transgenic macrophages against HIV-1 infection, in Gene Therapy, vol. 14, n. 14, 2007, pp. 1287–1297, DOI:10.1038/sj.gt.3302958, PMID 17597795.
Galvani AP, Slatkin M, Evaluating plague and smallpox as historical selective pressures for the CCR5-Delta 32 HIV-resistance allele, in Proc. Natl. Acad. Sci. U.S.A., vol. 100, n. 25, dicembre 2003, pp. 15276–9, DOI:10.1073/pnas.2435085100, PMC 299980, PMID 14645720.
Stephens JC, Reich DE, Goldstein DB, Shin HD, Smith MW, Carrington M, Winkler C, Huttley GA, Allikmets R, Schriml L, Gerrard B, Malasky M, Ramos MD, Morlot S, Tzetis M, Oddoux C, di Giovine FS, Nasioulas G, Chandler D, Aseev M, Hanson M, Kalaydjieva L, Glavac D, Gasparini P, Kanavakis E, Claustres M, Kambouris M, Ostrer H, Duff G, Baranov V, Sibul H, Metspalu A, Goldman D, Martin N, Duffy D, Schmidtke J, Estivill X, O'Brien SJ, Dean M, Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes, in Am. J. Hum. Genet., vol. 62, n. 6, giugno 1998, pp. 1507–15, DOI:10.1086/301867, PMC 1377146, PMID 9585595.
Buseyne F, Janvier G, Teglas JP, Ivanoff S, Burgard M, Bui E, Mayaux MJ, Blanche S, Rouzioux C, Rivière Y, Impact of heterozygosity for the chemokine receptor CCR5 32-bp-deleted allele on plasma virus load and CD4 T lymphocytes in perinatally human immunodeficiency virus-infected children at 8 years of age, in J. Infect. Dis., vol. 178, n. 4, ottobre 1998, pp. 1019–23, DOI:10.1086/515660, PMID 9806029.
Faure E, Royer-Carenzi M, Is the European spatial distribution of the HIV-1-resistant CCR5-Delta32 allele formed by a breakdown of the pathocenosis due to the historical Roman expansion?, in Infect. Genet. Evol., vol. 8, n. 6, dicembre 2008, pp. 864–74, DOI:10.1016/j.meegid.2008.08.007, PMID 18790087.
Freitas T, Brehm A, Fernandes AT, Frequency of the CCR5-delta32 mutation in the Atlantic island populations of Madeira, the Azores, Cabo Verde, and São Tomé e Príncipe, in Hum. Biol., vol. 78, n. 6, dicembre 2006, pp. 697–703, DOI:10.1353/hub.2007.0011, PMID 17564248.
Hedrick PW, Verrelli BC, "Ground truth" for selection on CCR5-Delta32, in Trends Genet., vol. 22, n. 6, giugno 2006, pp. 293–6, DOI:10.1016/j.tig.2006.04.007, PMID 16678299.
Glass WG, McDermott DH, Lim JK, Lekhong S, Yu SF, Frank WA, Pape J, Cheshier RC, Murphy PM, CCR5 deficiency increases risk of symptomatic West Nile virus infection, in J. Exp. Med., vol. 203, n. 1, gennaio 2006, pp. 35–40, DOI:10.1084/jem.20051970, PMC 2118086, PMID 16418398.
Duncan SR, Scott S, Duncan CJ, Reappraisal of the historical selective pressures for the CCR5-Delta32 mutation, in J. Med. Genet., vol. 42, n. 3, marzo 2005, pp. 205–8, DOI:10.1136/jmg.2004.025346, PMC 1736018, PMID 15744032.
Sabeti PC, Walsh E, Schaffner SF, Varilly P, Fry B, Hutcheson HB, Cullen M, Mikkelsen TS, Roy J, Patterson N, Cooper R, Reich D, Altshuler D, O'Brien S, Lander ES, The case for selection at CCR5-Delta32, in PLoS Biol., vol. 3, n. 11, novembre 2005, pp. e378, DOI:10.1371/journal.pbio.0030378, PMC 1275522, PMID 16248677.
Steinberger P, Andris-Widhopf J, Bühler B, Torbett BE, Barbas CF, Functional deletion of the CCR5 receptor by intracellular immunization produces cells that are refractory to CCR5-dependent HIV-1 infection and cell fusion, in Proc. Natl. Acad. Sci. U.S.A., vol. 97, n. 2, gennaio 2000, pp. 805–10, DOI:10.1073/pnas.97.2.805, PMC 15412, PMID 10639161.
Hütter G, Nowak D, Mossner M, Ganepola S, Müssig A, Allers K, Schneider T, Hofmann J, Kücherer C, Blau O, Blau IW, Hofmann WK, Thiel E, Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation, in N. Engl. J. Med., vol. 360, n. 7, febbraio 2009, pp. 692–8, DOI:10.1056/NEJMoa0802905, PMID 19213682.
Agrawal L, Lu X, Qingwen J, VanHorn-Ali Z, Nicolescu IV, McDermott DH, Murphy PM, Alkhatib G, Role for CCR5Delta32 protein in resistance to R5, R5X4, and X4 human immunodeficiency virus type 1 in primary CD4+ cells, in J. Virol., vol. 78, n. 5, marzo 2004, pp. 2277–87, DOI:10.1128/JVI.78.5.2277-2287.2004, PMC 369216, PMID 14963124.
Allers K, Hütter G, Hofmann J, Loddenkemper C, Rieger K, Thiel E, Schneider T, Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation, in Blood, vol. 117, n. 10, dicembre 2010, pp. 2791–2799, DOI:10.1182/blood-2010-09-309591, PMID 21148083.

nytimes.com

Nicholas Wade, Zinc Fingers Could Be Key to Reviving Gene Therapy, in The New York Times, 28 dicembre 2009. URL consultato il 30 dicembre 2009.

oadoi.org

Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, Farber CM, Saragosti S, Lapoumeroulie C, Cognaux J, Forceille C, Muyldermans G, Verhofstede C, Burtonboy G, Georges M, Imai T, Rana S, Yi Y, Smyth RJ, Collman RG, Doms RW, Vassart G, Parmentier M, Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene, in Nature, vol. 382, n. 6593, agosto 1996, pp. 722–5, DOI:10.1038/382722a0, PMID 8751444.
Samson M, Labbe O, Mollereau C, Vassart G, Parmentier M, Molecular cloning and functional expression of a new human CC-chemokine receptor gene, in Biochemistry, vol. 35, n. 11, marzo 1996, pp. 3362–7, DOI:10.1021/bi952950g, PMID 8639485.
Slimani H, Charnaux N, Mbemba E, Saffar L, Vassy R, Vita C, Gattegno L, Interaction of RANTES with syndecan-1 and syndecan-4 expressed by human primary macrophages, in Biochim. Biophys. Acta, vol. 1617, 1–2, ottobre 2003, pp. 80–8, DOI:10.1016/j.bbamem.2003.09.006, PMID 14637022.
Struyf S, Menten P, Lenaerts JP, Put W, D'Haese A, De Clercq E, Schols D, Proost P, Van Damme J, <2170::AID-IMMU2170>3.0.CO;2-D Diverging binding capacities of natural LD78beta isoforms of macrophage inflammatory protein-1alpha to the CC chemokine receptors 1, 3 and 5 affect their anti-HIV-1 activity and chemotactic potencies for neutrophils and eosinophils, in Eur. J. Immunol., vol. 31, n. 7, luglio 2001, pp. 2170–8, DOI:10.1002/1521-4141(200107)31:7<2170::AID-IMMU2170>3.0.CO;2-D, PMID 11449371.
Proudfoot AE, Fritchley S, Borlat F, Shaw JP, Vilbois F, Zwahlen C, Trkola A, Marchant D, Clapham PR, Wells TN, The BBXB motif of RANTES is the principal site for heparin binding and controls receptor selectivity, in J. Biol. Chem., vol. 276, n. 14, aprile 2001, pp. 10620–6, DOI:10.1074/jbc.M010867200, PMID 11116158.
Miyakawa T, Obaru K, Maeda K, Harada S, Mitsuya H, Identification of amino acid residues critical for LD78beta, a variant of human macrophage inflammatory protein-1alpha, binding to CCR5 and inhibition of R5 human immunodeficiency virus type 1 replication, in J. Biol. Chem., vol. 277, n. 7, febbraio 2002, pp. 4649–55, DOI:10.1074/jbc.M109198200, PMID 11734558.
Anderson J, Akkina R, Complete Knockdown of CCR5 by lentiviral vector-expressed siRNAs and protection of transgenic macrophages against HIV-1 infection, in Gene Therapy, vol. 14, n. 14, 2007, pp. 1287–1297, DOI:10.1038/sj.gt.3302958, PMID 17597795.
Faure E, Royer-Carenzi M, Is the European spatial distribution of the HIV-1-resistant CCR5-Delta32 allele formed by a breakdown of the pathocenosis due to the historical Roman expansion?, in Infect. Genet. Evol., vol. 8, n. 6, dicembre 2008, pp. 864–74, DOI:10.1016/j.meegid.2008.08.007, PMID 18790087.
Hütter G, Nowak D, Mossner M, Ganepola S, Müssig A, Allers K, Schneider T, Hofmann J, Kücherer C, Blau O, Blau IW, Hofmann WK, Thiel E, Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation, in N. Engl. J. Med., vol. 360, n. 7, febbraio 2009, pp. 692–8, DOI:10.1056/NEJMoa0802905, PMID 19213682.
Allers K, Hütter G, Hofmann J, Loddenkemper C, Rieger K, Thiel E, Schneider T, Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation, in Blood, vol. 117, n. 10, dicembre 2010, pp. 2791–2799, DOI:10.1182/blood-2010-09-309591, PMID 21148083.

plos.org

journals.plos.org

John Novembre, Alison P Galvani e Montgomery Slatkin, The Geographic Spread of the CCR5 Δ32 HIV-Resistance Allele, in PLOS Biology, 18 ottobre 2005.

science.org

(EN) Fiorenza Cocchi, Anthony L. DeVico e Paolo Lusso, Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8 + T Cells, in Science, vol. 270, n. 5243, 15 dicembre 1995, pp. 1811–1815, DOI:10.1126/science.270.5243.1811. URL consultato l'11 dicembre 2024.

web.archive.org

Genetics Home Reference (archiviato dall'url originale il 24 settembre 2009).
Delta32 Genetic Testing (PDF), su Briefing paper for AFAO members, Australian Federation of AIDS Organisations, 1º giugno 2007. URL consultato il 22 gennaio 2011 (archiviato dall'url originale il 19 marzo 2012).

wsj.com

online.wsj.com

Schoofs M, A Doctor, a Mutation and a Potential Cure for AIDS, in The Wall Street Journal, 7 novembre 2008. URL consultato il 15 dicembre 2010.